Find a TenderAwarded
Published 26 Jun 2024, 14:59 BST

Official UK procurement notice

NHS National Framework for Transition products commencing 1 October 2024

Official notice

Authority: NHS England (Central government)

Framework agreement2 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)£131,960,000total for 2 lots · framework ceiling, not attributable revenue
Submissions closed 29 Jul 2024awarded 30 Sept 2024
Lots 2see the lot list below
Framework period 1 yr 8 moends 31 May 2026 · extension options published · starts 1 Oct 2024

Re-procurement openNHS National Framework for Lenvatinib · bids close

What is being bought2 lots · detail below

Published requirement description

Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
25 bids on the busiest of 2 lots · 12 suppliers appointed
Framework period
1 yr 8 mo from 1 Oct 2024

Lots and requirements (2)Procurement structure

2 lots · all with a published value
Lot #1CM/TNS/24/5712/01Awarded 1 yr 8 moPublished value£131,150,000

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Additional information: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

Contract period: 1 Oct 2024 – 31 May 2026 (1 yr 8 mo)
Delivery: UK · Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsVariant bids: not allowed
Lot #2CM/TNS/24/5712/02Awarded 1 yrPublished value£810,000

CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Additional information: CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

Contract period: 1 Oct 2024 – 30 Sept 2025 (1 yr)
Delivery: UK · Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsVariant bids: not allowed

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS National Framework for Transition products commencing 1 October 2024” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
26 Jun 2024, 14:59 BST
Last source update
17 Oct 2024, 16:47 BST
Award evaluation window
29 Jul 2024 – …
Authority reference
CM/TNS/24/5712
FTS notice number
2024/S 000-033646
Classification (CPV)
Pharmaceutical products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-0472c3 Find a Tender
Contract terms
Electronic trading
electronic ordering · electronic payment

Publisher note: RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click "Register Interest"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replacedsid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select "Register" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S®Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated

Tender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗

Appointment period ends
29 Jul 2024, 13:00 BST
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bids opened
29 Jul 2024, 13:00 BST
Detailed submission instructions & authority contactsFrom official release

Timeline

29 Jul 2024 → 27 Oct 2024 · 5 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    29 Jul 2024, 13:00 BST
  2. Bids opened
    29 Jul 2024, 13:00 BST
  3. Contract starts
    1 Oct 2024, 00:00 BST
  4. Notice published
    17 Oct 2024, 16:47 BST
  5. Bids must remain valid until
    27 Oct 2024, 23:59 GMT

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to complete
    17 Oct 2024, 16:47 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 12admitted to the panel · see the list ↓
Bids received 2514 from SMEs · busiest of 2 lots
Contracts signed 13latest 30 Sept 2024

13 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 13 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 30 Sept 2025
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active
  • Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

    Signed
    30 Sept 2024
    Value
    ceiling above
    Period
    … – 31 May 2026
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · CM/TNS/24/5712/0125bids · 25 electronic · 25 from abroad14——
2 · CM/TNS/24/5712/026bids · 6 electronic · 6 from abroad4——

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 7-8 Wellington Place, Leeds, UK, LS1 4APContact name, email Published organisation website ↗

Dispute resolution & review bodies

  • The High CourtReview body London

Framework contractors & participating bidders

12 commercial parties on the notice
  • Accord-UK LtdFramework contractor00079585 Accord-UK Ltd Whiddon Valley,, Barnstaple, Devon,, UK, EX32 8NS
  • Amarox LimitedFramework contractor10997632 Amarox Limited Congress House, 14 Lyon Road, Harrow,, Middlesex, UK, HA1 2EN
  • Celix Pharma Ltd.Framework contractor12474195 Celix Pharma Ltd. 12 Constance Street, International House,, London, UK, E16 2DQ
  • Dr.Reddy's Laboratories (UK) LimitedFramework contractor1729064 Dr.Reddy's Laboratories (UK) Ltd 410, Cambridge Science Park Milton Rd, Milton,, Cambridge, UK, CB4 0PE
  • Gilead Sciences LimitedFramework contractor02543818 Gilead Sciences LTD 280 High Holborn,, London, UK, WC1V 7EE
  • Glenmark Pharmaceuticals Europe LimitedFramework contractor5040260 Glenmark Pharmaceuticals Europe Limited 2-B Laxmi House, Draycott Avenue Kenton,, Harrow, Middlesex,, UK, HA3 0BU
  • Mercury Pharmaceuticals LimitedFramework contractor02619880 Mercury Pharmaceuticals Limited Dashwood House, 69 Old Broad Street,, London,, UK, EC2M 1QS
  • Seacross Pharmaceuticals LtdFramework contractor07650983 Seacross Pharmaceuticals Ltd. Stanmore Business & Innovation Centre, Stanmore Place,, London, UK
  • Teva UK LimitedFramework contractor00302461 Teva UK Ridings Point, Whistler Drive,, Castleford,, UK, WF10 5HX
  • Thornton and Ross LtdFramework contractor00185947 Thornton & Ross Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, UK, HD7 5QH
Show 2 more suppliers
  • Tillomed Laboratories ltdFramework contractor2544103 Tillomed Laboratories ltd 220 Butterfield Great Marlings, Luton, UK, LU2 8DL
  • Zentiva Pharma UK LtdFramework contractor2158996 Zentiva Pharma UK Limited 12 New Fetter Lane,, London, UK, EC4A 1JP

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria
  • Technical selection criteriatenderTechnical selection criteria